Whitney Pope, MD, PhD

Whitney Pope, MD, PhD

Professor in Residence, Department of Radiology
Director, UCLA Brain Tumor Imaging




Diagnostic Neuroradiology

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
West Los Angeles Veterans Affairs Medical Center



Neuroradiology, UCLA School of Medicine, 2003 - 2004


Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, 1998 - 1999


MD, University of Illinois College of Medicine at Chicago, 1998
PhD, Northwestern University, 1994


Radiology, UCLA School of Medicine, 1999 - 2003

Board Certifications

Neuroradiology, American Board of Radiology, 2008
Diagnostic Radiology, American Board of Radiology, 2003

Contact Information

Clinical Interests

Brain Tumors, Molecular Imaging of Functional Markers

Scientific Interests

Dr. Whitney Pope is interested in the molecular imaging of gliobastoma multiforme and the imaging and molecular diagnostic strategies in the prognosis and management of gliomas.

Highlighted Publications

Carrillo JA, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, Moftakhar P, Lalaezari S, Yong W, Ellingson BM, Cloughesy TF, Pope WB. Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. AJNR Am J Neuroradiol. 2012 Aug;33(7):1349-55. Epub 2012 Feb 9

Pope WB, Mirsadraei L, Lai A, Eskin A, Qiao J, Kim HJ, Ellingson B, Nghiemphu PL, Kharbanda S, Soriano RH, Nelson SF, Yong W, Phillips HS, Cloughesy TF. Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. AJNR Am J Neuroradiol. 2012 Jun;33(6):1059-64. Epub 2012 Jan 19

Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol. 2012 Mar;107(1):197-205. Epub 2011 Oct 21

Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Rn PL, Prados M, Goldin J, Wen PY, Cloughesy T. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol. 2012 Jul;108(3):491-8. Epub 2012 Mar 18

Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol. 2011 Dec 1;29(34):4482-90. Epub 2011 Oct 24